KZR
Kezar Life Sciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.85
-0.33 ▼ -4.60%
🌙 3월 13일 4:48 PM ET (한국 3/14 05:48)
$7.08
+0.23 ▲ +3.36%
| Index | - | P/E | - | EPS (ttm) | -8.44 | Insider Own | 12.14% | Shs Outstand | 0.01B | Perf Week | -1.3% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | 29.25% | Insider Trans | - | Shs Float | 0.01B | Perf Month | 8.04% |
| Enterprise Value | -0.03B | PEG | - | EPS next Q | -1.31 | Inst Own | 60.91% | Short Float | 2.74% | Perf Quarter | 7.87% |
| Income | -0.06B | P/S | - | EPS this Y | 41.65% | Inst Trans | 5.09% | Short Ratio | 4.5 | Perf Half Y | 72.11% |
| Sales | 0.00B | P/B | 0.6 | EPS next 5Y | 26.34% | ROA | -47.14% | Short Interest | 0.18M | Perf YTD | 8.9% |
| Book/sh | 11.33 | P/C | 0.56 | EPS past 3/5Y | -3.52% 8.98% | ROE | -56.86% | 52W High | -8.05% ($7.45) | Perf Year | 17.5% |
| Cash/sh | 12.32 | P/FCF | - | Sales past 3/5Y | - | ROIC | -73.15% | 52W Low | 93.86% ($3.53) | Perf 3Y | -86.7% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 35.8% | Gross Margin | - | Volatility(W/M) | 4.19% 3.89% | Perf 5Y | -89.93% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.26 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.06 | EPS Q/Q | 44.93% | Profit Margin | - | RSI (14) | 52.91 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.06 | Sales Q/Q | - | SMA20 | 0.14% ($6.84) | Beta | 0.47 | Target Price | $7 |
| Payout | - | Debt/Eq | 0.12 | Earnings | 11000000 | SMA50 | 6.11% ($6.46) | Rel Volume | 0.28 | Prev Close | $7.18 |
| Employees | 55 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 25.64% - | SMA200 | 30.1% ($5.27) | Avg Volume(3M) | 0.04M | Price | $6.85 |
| IPO | 2018/6/21 | Option/Short | Yes/Yes | Trades | 105 | Volume | 11,013 | Change | -4.6% |
뉴스 로딩 중...